We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Philips, Medtronic Lead in Patient Monitors

By HospiMedica International staff writers
Posted on 23 Apr 2013
Royal Philips Electronics (Philips; Amsterdam, The Netherlands) and Medtronic (Minneapolis, MN, USA) are the leading companies in remote patient monitoring. More...
These are the latest findings of Kalorama Information (New York, NY, USA), an independent medical market research firm.

Both of the market-leading companies have boosted their market share by focusing on certain types of monitoring, according to the Kalorama report. Philips SureSigns monitors measure vital signs, electrocardiogram (ECG), and respiratory functions, while the Medtronic Reveal DX and XT series of insertable monitors are aimed at cardiac patients. But while these companies are able to leverage existing sales to hospitals and rapid product introductions to maintain market share, there are many smaller companies who still represent a sizable portion of the market.

The most prominent of these are Covidien (Dublin, Ireland), who produces a variety of oximetry and capnography systems, and Hoffmann-La Roche (Roche; Basel, Switzerland), whose AccuCheck line of glucose monitors now includes products with remote capability. In all, Kalorama Information found that these four companies together have over 35% of the global market. Double-digit revenue growth leads Kalorama to expect more competitors and more products.

Other companies with a presence in the field include Chinese company Mindray, with its Passport portable monitors; Japan-based Omron’s marketing blood pressure and ECG systems; and Masimo (Irvine, CA, USA) with its Rainbow SET pulse oximetry systems. There are also very large numbers of companies offering some form of wireless and remote technologies for patient monitoring, most of them large, established healthcare companies that work in conjunction with information technology (IT) companies on an entire system.

“Large vendors dominate, but half of the revenue of this market are small players with nominal global market share,” said Bruce Carlson, Publisher of Kalorama Information. “Small vendors will drive growth in the market and offer cheaper or more effective products. This is particularly true in the home care and telemedicine segment.”

Related Links:
Royal Philips Electronics
Medtronic
Kalorama Information


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Captivator EMR Device
Captivator Endoscopic Mucosal Resection Device
New
Critical Care Cart
Avalo
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: Bioprinting synthetic vasculature could dramatically change how cardiovascular diseases are treated (Dell, A.C., Maresca, J., Davis, B.A. et al.; doi.org/10.1038/s41598-025-93276-y)

Bioprinted Aortas Offer New Hope for Vascular Repair

Current treatment options for severe cardiovascular diseases include using grafts made from a patient's own tissue (autologous) or synthetic materials. However, autologous grafts require invasive surgery... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.